a2 Milk has patented a method for treating irritable bowel syndrome in adults by replacing bovine milk with a composition containing at least 50% beta-casein A2. This method aims to reduce inflammation of the bowel induced by beta-casomorphin-7 (BCM-7) in the diet. GlobalData’s report on a2 Milk gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on a2 Milk, Whey protein compositions was a key innovation area identified from patents. a2 Milk's grant share as of February 2024 was 78%. Grant share is based on the ratio of number of grants to total number of patents.
Patent granted for treating irritable bowel syndrome with a2 milk
A recently granted patent (Publication Number: US11911439B2) discloses a method for treating irritable bowel syndrome in adult humans who consume bovine milk or bovine milk products containing beta-casein A1 and beta-casein A2. The method involves replacing the bovine milk or milk product in their diet with a version that does not contain beta-casein A1, specifically targeting cases where irritable bowel syndrome is induced by beta-casomorphin-7 (BCM-7) exclusively.
The patent further specifies that the milk used in the method can be in various forms such as fresh milk, milk powder, liquid milk reconstituted from powder, skim milk, homogenised milk, condensed milk, evaporated milk, pasteurised milk, non-pasteurised milk, or UHT milk. Additionally, the method extends to milk products like cream, yoghurt, quark, cheese, butter, or ice cream. Interestingly, the patent also highlights that the method is particularly applicable to adult women suffering from irritable bowel syndrome, emphasizing a potential gender-specific aspect to the treatment approach.
To know more about GlobalData’s detailed insights on a2 Milk, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
